WallStSmart

Covista Inc. (CVSA)vsJIADE LIMITED Common stock (JDZG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 7331% more annual revenue ($1.91B vs $25.70M). CVSA leads profitability with a 12.3% profit margin vs -41.2%. CVSA earns a higher WallStSmart Score of 56/100 (C).

CVSA

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 7.5Value: 6.3Quality: 6.5
Piotroski: 6/9Altman Z: 3.09

JDZG

Avoid

24

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 3.69

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

JDZG4 strengths · Avg: 9.8/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
66.2%10/10

Revenue surging 66.2% year-over-year

Altman Z-ScoreHealth
3.6910/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Areas to Watch

CVSA2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

EPS GrowthGrowth
-24.6%2/10

Earnings declined 24.6%

JDZG4 concerns · Avg: 2.8/10
Market CapQuality
$94.00M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.3%3/10

ROE of 2.3% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-91.4%2/10

Earnings declined 91.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, Price/Book. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : JDZG

The strongest argument for JDZG centers on Price/Book, Revenue Growth, Altman Z-Score. Revenue growth of 66.2% demonstrates continued momentum.

Bear Case : CVSA

The primary concerns for CVSA are Revenue Growth, EPS Growth.

Bear Case : JDZG

The primary concerns for JDZG are Market Cap, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while JDZG is a hypergrowth play — different risk/reward profiles.

JDZG carries more volatility with a beta of 2.10 — expect wider price swings.

JDZG is growing revenue faster at 66.2% — sustainability is the question.

CVSA generates stronger free cash flow (166M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (56/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

JIADE LIMITED Common stock

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · China

JIADE LIMITED (Ticker: JDZG) is an innovative player in the e-commerce and technology industries, dedicated to enhancing consumer engagement through cutting-edge solutions. The company emphasizes sustainable growth via significant investments in research and development, positioning itself as a leader in adapting to market trends. With a robust network of strategic partnerships and a commitment to exceptional customer satisfaction, JIADE LIMITED is poised to provide substantial long-term value, making it an appealing option for institutional investors looking for growth and stability in their investment portfolios.

Visit Website →

Want to dig deeper into these stocks?